Year-end Sale % OFF 
Abstract
Antimicrobial resistance (AMR) which is considered a significant global health crisis continues to evolve and spread across the globe. If no adequate strategies are put in place to halt its rapid spread, routine surgical and medical procedures would become impossible without effective antimicrobials. By the year 2050, AMR is estimated to cost 10 million lives and about US$100 trillion annually. Growing concerns due to the escalating spread of multidrug resistant organisms have forced the World Health Organisation (WHO), the Centre for Disease Control and Prevention (CDC), European Commission of the EU, the UK Department of Health and the African Academy of Sciences to put strategies against AMR in place. However, despite efforts to halt AMR, recent reports show disturbing trends of difficult-to-treat deadly infections including gonorrhoea, typhoid, pneumonia, influenza, HIV, malaria and tuberculosis. This article bolsters the need for a comprehensive, real-time and improved surveillance of multidrug resistant organisms, sustained and coordinated action against AMR, development of new antibiotics and vaccines, prevention and control of diseases, improved sanitation and hygiene, sustained research, development of rapid diagnostics as well as provision of affordable and accessible health services.
Highlights
Antimicrobial resistance (AMR) is a major global public health threat
The global annual mortality rate due to AMR is estimated to be 700,000 and by the year 2050, if no adequate strategies are put in place to halt its rapid spread, it is estimated to cost 10 million lives and about US$100 trillion annually.[1]
The problem of AMR may continue to linger since the issue of widespread consumer abuse of antibiotics, which is a major driver of AMR is very difficult to confront, especially in remote localities of developing countries with no health facilities
Summary
The global annual mortality rate due to AMR is estimated to be 700,000 and by the year 2050, if no adequate strategies are put in place to halt its rapid spread, it is estimated to cost 10 million lives and about US$100 trillion annually.[1] The World Health Organization, the Centre for Disease Control, the Institute of Medicine and the Infectious Diseases Society of America have all declared AMR as a global public health crisis.[2] There is no doubt that the threat posed by AMR is significant. Many countries of the world are yet to fully recognise how If appropriate and timely actions are not taken, there is a serious concern that the role of antibiotics in reducing the mortality and morbidity rates of infectious diseases is threatened.[1]
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
